封面
市场调查报告书
商品编码
1386522

智慧药丸市场报告:2030 年趋势、预测与竞争分析

Smart Pills Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

智慧药丸趋势与预测

预计到 2030 年,全球智慧药丸市场将达到 13 亿美元,2024 年至 2030 年年复合成长率为 11.6%。该市场的主要驱动因素是对非侵入性诊断监测设备的需求不断增长、结肠癌发病率上升以及胶囊内视镜技术的不断进步。全球智慧药丸市场前景广阔,胶囊内视镜、标靶给药、未来性征象监测市场蕴藏商机。

智慧药丸市场洞察

Lucintel 预测,由于克隆氏症、乳糜泻和小肠肿瘤等小肠疾病的显着增加,小肠在预测期内将出现最高增长。

由于胃肠道疾病的增加和对非侵入性诊断方法的偏好,胶囊内视镜仍然是该市场的最大细分市场。

由于发炎性肠道疾病疾病的盛行率不断上升以及该地区新产品的监管核准,预计北美地区在预测期内将出现最高的增长。

本报告回答了 11 个关键问题:

  • Q.1. 细分市场中最有前途和高成长的机会是什么?
  • Q.2.哪个细分市场将以更快的速度成长?为什么?
  • Q.3.您认为哪些地区未来会出现更快的成长?为什么?
  • Q.4. 影响市场动态的主要因素有哪些?市场的主要挑战和商业风险是什么?
  • Q.5. 这个市场的商业风险和竞争威胁是什么?
  • Q.6.这个市场有哪些新趋势?为什么?
  • Q.7.市场客户需求有何改变?
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位?
  • Q.9.这个市场的主要企业有哪些?主要企业采取哪些策略配合措施来发展业务?
  • Q.10. 该市场上的竞争产品有哪些?由于材料或产品替代而导致市场占有率下降的威胁有多大?
  • Q.11.过去年度发生了哪些併购事件,对产业产生了哪些影响?

目录

第1章执行摘要

第2章全球智慧药丸市场:市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势(2018-2023)与预测(2024-2030)
  • 全球智慧药丸市场趋势(2018-2023)与预测(2024-2030)
  • 按目标区域分類的全球智慧药丸市场
    • 食道
    • 小肠
    • 大肠
  • 按应用分類的全球智慧药丸市场
    • 胶囊内视镜
    • 靶向药物输送
    • 生命征象监测
  • 按最终用途分類的全球智慧药丸市场
    • 医院
    • 诊断中心
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球智慧药丸市场(按地区)
  • 北美智慧药丸市场
  • 欧洲智慧药丸市场
  • 亚太地区智慧药丸市场
  • 其他地区智能药丸市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按目标区域分類的全球智慧药丸市场成长机会
    • 全球智慧药丸市场成长机会(按应用)
    • 全球智慧药丸市场成长机会(依最终用途)
    • 按地区分類的全球智慧药丸市场成长机会
  • 全球智慧药丸市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球智慧药丸市场产能
    • 全球智慧药丸市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • Medtronic
  • HQ
  • IntroMedic
  • OLYMPUS Corporation
  • Koninklijke Philips NV
  • Check-Cap
  • JINSHAN Science & Technology
  • CapsoVision
  • RF Co.
  • Proteus Digital Health
简介目录

Smart Pills Trends and Forecast

The future of the global smart pills market looks promising with opportunities in the capsule endoscopy, targeted drug delivery, and vital sign monitoring markets. The global smart pills market is expected to reach an estimated $1.3 billion by 2030 with a CAGR of 11.6% from 2024 to 2030. The major drivers for this market are growing demand for noninvasive diagnostic monitoring devices, rising incidence of colon cancer, and on-going technological advancements in capsule endoscopy.

A more than 150-page report is developed to help in your business decisions.

Smart Pills by Segment

The study includes a forecast for the global smart pills by target area, application, end use, and region

Smart Pills Market by Target Area [Shipment Analysis by Value from 2018 to 2030]:

  • Esophagus
  • Small Intestine
  • Large Intestine
  • Stomach

Smart Pills Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Capsule Endoscopy
  • Targeted Drug Delivery
  • Vital Sign Monitoring

Smart Pills Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Diagnostic Centers
  • Others

Smart Pills Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Smart Pills Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies smart pills companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the smart pills companies profiled in this report include-

  • Medtronic
  • HQ
  • IntroMedic
  • OLYMPUS Corporation
  • Koninklijke Philips N.V.
  • Check-Cap
  • JINSHAN Science & Technology
  • CapsoVision
  • RF Co.
  • Proteus Digital Health

Smart Pills Market Insights

Lucintel forecast that small intestine is expected to witness highest growth over the forecast period due to the notable rise in small intestine disorders, such as crohn's disorders, celiac disorders, and small bowel tumors.

Within this market, capsule endoscopy will remain the largest segment due to the increasing number of gastrointestinal disorders and rising prefrence towards non-invasive diagnostic procedures.

North America is expected to witness highest growth over the forecast period due to growing incidence of inflammatory bowel diseases and regulatory approval of new products in the region.

Features of the Global Smart Pills Market

Market Size Estimates: Smart pills market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Smart pills market size by target area, application, end use, and region in terms of value ($B).

Regional Analysis: Smart pills market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different target areas, applications, end uses, and regions for the smart pills market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the smart pills market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the smart pills market size?

Answer: The global smart pills market is expected to reach an estimated $1.3 billion by 2030.

Q.2 What is the growth forecast for smart pills market?

Answer: The global smart pills market is expected to grow with a CAGR of 11.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the smart pills market?

Answer: The major drivers for this market are growing demand for noninvasive diagnostic monitoring devices, rising incidence of colon cancer, and on-going technological advancements in capsule endoscopy.

Q4. What are the major segments for smart pills market?

Answer: The future of the smart pills market looks promising with opportunities in the capsule endoscopy, targeted drug delivery, and vital sign monitoring markets.

Q5. Who are the key smart pills market companies?

Answer: Some of the key smart pills companies are as follows:

  • Medtronic
  • HQ
  • IntroMedic
  • OLYMPUS Corporation
  • Koninklijke Philips N.V.
  • Check-Cap
  • JINSHAN Science & Technology
  • CapsoVision
  • RF Co.
  • Proteus Digital Health

Q6. Which smart pills market segment will be the largest in future?

Answer: Lucintel forecast that small intestine is expected to witness highest growth over the forecast period due to the notable rise in small intestine disorders, such as crohn's disorders, celiac disorders, and small bowel tumors.

Q7. In smart pills market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to growing incidence of inflammatory bowel diseases and regulatory approval of new products in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the smart pills market by target area (esophagus, small intestine, large intestine, and stomach), application (capsule endoscopy, targeted drug delivery, and vital sign monitoring), end use (hospitals, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Smart Pills Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Smart Pills Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Smart Pills Market by Target Area
    • 3.3.1: Esophagus
    • 3.3.2: Small Intestine
    • 3.3.3: Large Intestine
    • 3.3.4: Stomach
  • 3.4: Global Smart Pills Market by Application
    • 3.4.1: Capsule Endoscopy
    • 3.4.2: Targeted Drug Delivery
    • 3.4.3: Vital Sign Monitoring
  • 3.5: Global Smart Pills Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Diagnostic Centers
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Smart Pills Market by Region
  • 4.2: North American Smart Pills Market
    • 4.2.2: North American Smart Pills Market by Application: Capsule Endoscopy, Targeted Drug Delivery, and Vital Sign Monitoring
  • 4.3: European Smart Pills Market
    • 4.3.1: European Smart Pills Market by Target Area: Esophagus, Small Intestine, Large Intestine, and Stomach
    • 4.3.2: European Smart Pills Market by Application: Capsule Endoscopy, Targeted Drug Delivery, and Vital Sign Monitoring
  • 4.4: APAC Smart Pills Market
    • 4.4.1: APAC Smart Pills Market by Target Area: Esophagus, Small Intestine, Large Intestine, and Stomach
    • 4.4.2: APAC Smart Pills Market by Application: Capsule Endoscopy, Targeted Drug Delivery, and Vital Sign Monitoring
  • 4.5: ROW Smart Pills Market
    • 4.5.1: ROW Smart Pills Market by Target Area: Esophagus, Small Intestine, Large Intestine, and Stomach
    • 4.5.2: ROW Smart Pills Market by Application: Capsule Endoscopy, Targeted Drug Delivery, and Vital Sign Monitoring

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Smart Pills Market by Target Area
    • 6.1.2: Growth Opportunities for the Global Smart Pills Market by Application
    • 6.1.3: Growth Opportunities for the Global Smart Pills Market by End Use
    • 6.1.4: Growth Opportunities for the Global Smart Pills Market by Region
  • 6.2: Emerging Trends in the Global Smart Pills Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Smart Pills Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Smart Pills Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Medtronic
  • 7.2: HQ
  • 7.3: IntroMedic
  • 7.4: OLYMPUS Corporation
  • 7.5: Koninklijke Philips N.V.
  • 7.6: Check-Cap
  • 7.7: JINSHAN Science & Technology
  • 7.8: CapsoVision
  • 7.9: RF Co.
  • 7.10: Proteus Digital Health